Selling And Administration Expenses Changement Date
Adma Biologics USD 16.22M 1.03M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Cytokinetics USD 44.11M 4M 2023-12
Dynavax Technologies USD 39.79M 2.63M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Heron Therapeutics USD 24.6M 11.84M 2023-09
Immunic USD 3.77M 75K 2023-09
Insmed USD 89.53M 1.1M 2023-12
Knight Therapeutics CAD 23M 1.01M 2023-09
Omeros USD 16.42M 5.16M 2023-09
Pacira USD 65.8M 2.15M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Regulus Therapeutics USD 2.64M 298K 2023-09
Rockwell Medical USD 3.44M 380K 2023-09
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
United Therapeutics USD 128.6M 1000K 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09
Xoma USD 6.37M 591K 2023-09



Omeros Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.